Figure 1.

miR-182 is over-expressed in human prostate tumors, and its up-regulation is associated with clinical progression. MiR-182 expression was measured using qRT-PCR in various prostate tumor samples representing different Gleason grades compared with normal prostate tissue. Sample categories were distributed as follows: Normal (n=5), Gleason 5 or 6 (n=32), Gleason 7 (n=101), Gleason 8 or 9 (n=14). All samples were normalized to RNU6B expression. Expression levels of miR-93 and miR-98 were also assessed, but did not show a significant difference. (* p < 0.05).